Abbott Laboratories (ABT)
Receivables turnover
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 41,950,000 | 41,217,000 | 40,725,000 | 40,326,000 | 40,109,000 | 39,959,000 | 40,226,000 | 41,505,000 | 43,653,000 | 45,030,000 | 45,548,000 | 44,514,000 | 43,075,000 | 42,308,000 | 40,233,000 | 37,338,000 | 34,608,000 | 32,221,000 | 31,444,000 | 32,095,000 |
Receivables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue (ttm) ÷ Receivables
= $41,950,000K ÷ $—K
= —
The receivables turnover ratio for Abbott Laboratories is not available for the periods specified (March 31, 2020 to December 31, 2024) in the provided data. The receivables turnover ratio measures how efficiently a company is collecting payments from its customers. A higher ratio indicates that the company is converting its accounts receivable into cash quickly, while a lower ratio may suggest potential issues with collecting payments on time. Without the specific data points, it is not possible to assess Abbott Laboratories' performance in managing its accounts receivable turnover over the specified periods. It is recommended to obtain the relevant financial figures to calculate the receivables turnover ratio and analyze the trend for a comprehensive assessment of the company's receivables management efficiency.
Peer comparison
Dec 31, 2024